Metformin selectively targets redox control of complex I energy transduction
Open Access
- 1 April 2018
- journal article
- research article
- Published by Elsevier BV in Redox Biology
- Vol. 14, 187-197
- https://doi.org/10.1016/j.redox.2017.08.018
Abstract
No abstract availableFunding Information
- Rural and Environment Science and Analytical Services Division
- Medical Research Council (MR/K012924/1)
- University of Dundee
- Engineering and Physical Sciences Research Council (EP/P001459/1)
- Diabetes UK (12/0004625)
- Tenovus
- Wellcome Trust
This publication has 52 references indexed in Scilit:
- Molecular mechanism of action of metformin: old or new insights?Diabetologia, 2013
- The Ancient Drug Salicylate Directly Activates AMP-Activated Protein KinaseScience, 2012
- Cellular Responses to the Metal-Binding Properties of MetforminDiabetes, 2012
- High Throughput Microplate Respiratory Measurements Using Minimal Quantities Of Isolated MitochondriaPLOS ONE, 2011
- Superoxide Is Produced by the Reduced Flavin in Mitochondrial Complex IJournal of Biological Chemistry, 2011
- Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signalingProceedings of the National Academy of Sciences of the United States of America, 2010
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy stateJCI Insight, 2010
- Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK ActivationCell Metabolism, 2010
- Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent MannerCell Metabolism, 2010
- Role of AMP-activated protein kinase in mechanism of metformin actionJCI Insight, 2001